Abrdn Life Sciences Investors (HQL)
NYSE: HQL · Real-Time Price · USD
20.12
+0.14 (0.70%)
Jul 2, 2026, 4:00 PM EDT - Market closed

HQL Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
612448412327343505
Market Cap Growth
-8.58%26.18%-4.83%-31.99%22.27%
Enterprise Value
611448412336352505
Last Close Price
20.1214.1011.998.808.7912.25
PE Ratio
3.095.234.8414.62-7.83
PS Ratio
551.30231.02103.6393.42113.77220.89
PB Ratio
1.090.870.900.810.860.97
P/TBV Ratio
1.090.870.900.810.860.97
P/OCF Ratio
15.3714.12----
EV/Sales Ratio
550.53231.02103.6396.09116.55220.89
Debt / Equity Ratio
----0.030.02
Net Debt / Equity Ratio
-0000.030.02
Asset Turnover
0.000.000.010.010.010.00
Quick Ratio
1.550.710.277.570.040.01
Current Ratio
1.610.730.3230.460.700.80
Return on Equity (ROE)
41.42%17.59%19.80%5.59%-22.71%12.82%
Return on Assets (ROA)
-0.61%-0.43%-0.28%-0.33%-0.39%-0.51%
Return on Capital Employed (ROCE)
-0.80%-0.70%-0.40%-0.50%-0.80%-0.80%
Earnings Yield
32.39%19.11%20.68%6.84%-30.45%12.78%
Dividend Yield
9.05%12.90%13.84%14.55%16.72%13.63%
Payout Ratio
31.30%36.96%----
Buyback Yield / Dilution
-5.32%-5.48%-4.74%-4.33%-4.10%-3.29%
Total Shareholder Return
3.73%7.43%9.10%10.22%12.62%10.35%
SEC Filings: 10-K · 10-Q